DE69635355D1 - Verfahren zum Nachweis von biologisch aktiven Substanzen - Google Patents

Verfahren zum Nachweis von biologisch aktiven Substanzen

Info

Publication number
DE69635355D1
DE69635355D1 DE69635355T DE69635355T DE69635355D1 DE 69635355 D1 DE69635355 D1 DE 69635355D1 DE 69635355 T DE69635355 T DE 69635355T DE 69635355 T DE69635355 T DE 69635355T DE 69635355 D1 DE69635355 D1 DE 69635355D1
Authority
DE
Germany
Prior art keywords
gfp
green fluorescent
sample
fluorescent protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635355T
Other languages
English (en)
Other versions
DE69635355T2 (de
Inventor
Ole Thastrup
Soren Tullin
Lars Kongsbak Poulsen
Sara Petersen Bjorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisher BioImage ApS
Original Assignee
BioImage AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioImage AS filed Critical BioImage AS
Publication of DE69635355D1 publication Critical patent/DE69635355D1/de
Application granted granted Critical
Publication of DE69635355T2 publication Critical patent/DE69635355T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE69635355T 1995-01-31 1996-01-31 Verfahren zum Nachweis von biologisch aktiven Substanzen Expired - Lifetime DE69635355T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK11095 1995-01-31
DK11095 1995-01-31

Publications (2)

Publication Number Publication Date
DE69635355D1 true DE69635355D1 (de) 2005-12-01
DE69635355T2 DE69635355T2 (de) 2006-08-03

Family

ID=35267649

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635355T Expired - Lifetime DE69635355T2 (de) 1995-01-31 1996-01-31 Verfahren zum Nachweis von biologisch aktiven Substanzen

Country Status (5)

Country Link
EP (1) EP1143011B1 (de)
AT (1) ATE307893T1 (de)
DE (1) DE69635355T2 (de)
DK (1) DK1143011T3 (de)
ES (1) ES2250259T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014012130B3 (de) 2014-08-13 2015-03-05 Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
CA2169298A1 (en) * 1993-09-10 1995-03-16 Martin Chalfie Uses of green fluorescent protein
WO1995021191A1 (en) * 1994-02-04 1995-08-10 William Ward Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein

Also Published As

Publication number Publication date
DE69635355T2 (de) 2006-08-03
DK1143011T3 (da) 2006-03-20
EP1143011A3 (de) 2004-03-31
EP1143011B1 (de) 2005-10-26
EP1143011A2 (de) 2001-10-10
ES2250259T3 (es) 2006-04-16
ATE307893T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
DE69618350T2 (de) Ein verfahren zum nachweis biologisch aktiver substanzen
DE69333289D1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
WO1999064592A3 (en) Green fluorescent proteins for measuring the ph of a biological sample
ATE397752T1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
WO1995015331B1 (en) SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
DE69939896D1 (de) Methoden zur detektion von nukleinsäuren unter verwendung von zymogenen und dazugehörige kits
DE69634696D1 (de) Verfahren und testsystem zur hybridisierungsanalyse unter verwendung von peptidnukleinsäure-sonden
DE60039072D1 (de) Verfahren zum screenen von mehrfach transformierteon von fluoreszenzproteinen
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
SE9500023L (sv) Sätt att detektera cancer
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
NO20010362L (no) Nukleinsyrer kodende for proteiner som er involvert i sensorisk transduksjon
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
DE69808930T2 (de) Leberfunktionstest
ATE225942T1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
ATE200709T1 (de) Htlv-i/htlv-ii assay und verfahren
DE69635355D1 (de) Verfahren zum Nachweis von biologisch aktiven Substanzen
ATE306666T1 (de) Verfahren zur eiweissanalyse
DE69428998T2 (de) Reagenzien und verfahren zur detektion und quantitativen bestimmung von testosteron in flüssigen proben
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
DE69632826D1 (de) Nukleinsaeure erkennung von hepatitis gb virus
WO2002050104A3 (en) Methods and cells for detecting modulators of rgs proteins
ATE269417T1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
ATE511539T1 (de) Bhlh-pas-proteine, deren gene und verwendung derselben
EP1136568A4 (de) Methode zum ermitteln der nukleinsäure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FISHER BIOLMAGE APS, SEOBORG, DK

8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1143011

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB